Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Can Interoception Improve the Pragmatic Search for Biomarkers in Psychiatry?

Khalsa SS, Lapidus RC.

Front Psychiatry. 2016 Jul 25;7:121. doi: 10.3389/fpsyt.2016.00121. eCollection 2016 Jul 25. Review.

2.

OREXIN 1 AND 2 RECEPTOR INVOLVEMENT IN CO2 -INDUCED PANIC-ASSOCIATED BEHAVIOR AND AUTONOMIC RESPONSES.

Johnson PL, Federici LM, Fitz SD, Renger JJ, Shireman B, Winrow CJ, Bonaventure P, Shekhar A.

Depress Anxiety. 2015 Sep;32(9):671-83. doi: 10.1002/da.22403. Epub 2015 Aug 19.

4.

Etiology, triggers and neurochemical circuits associated with unexpected, expected, and laboratory-induced panic attacks.

Johnson PL, Federici LM, Shekhar A.

Neurosci Biobehav Rev. 2014 Oct;46 Pt 3:429-54. doi: 10.1016/j.neubiorev.2014.07.027. Epub 2014 Aug 15. Review.

5.

Changes in cerebral blood flow after cognitive behavior therapy in patients with panic disorder: a SPECT study.

Seo HJ, Choi YH, Chung YA, Rho W, Chae JH.

Neuropsychiatr Dis Treat. 2014 Apr 17;10:661-9. doi: 10.2147/NDT.S58660. eCollection 2014 Apr 17.

6.

Acute shift in glutamate concentrations following experimentally induced panic with cholecystokinin tetrapeptide--a 3T-MRS study in healthy subjects.

Zwanzger P, Zavorotnyy M, Gencheva E, Diemer J, Kugel H, Heindel W, Ruland T, Ohrmann P, Arolt V, Domschke K, Pfleiderer B.

Neuropsychopharmacology. 2013 Aug;38(9):1648-54. doi: 10.1038/npp.2013.61. Epub 2013 Mar 5.

7.

An animal model of panic vulnerability with chronic disinhibition of the dorsomedial/perifornical hypothalamus.

Johnson PL, Shekhar A.

Physiol Behav. 2012 Dec 5;107(5):686-98. doi: 10.1016/j.physbeh.2012.03.016. Epub 2012 Mar 26. Review.

8.

Psychopharmacology of anxiety disorders.

Cassano GB, Baldini Rossi N, Pini S.

Dialogues Clin Neurosci. 2002 Sep;4(3):271-85.

9.
10.

Selective GABAergic treatment for panic? Investigations in experimental panic induction and panic disorder.

Zwanzger P, Rupprecht R.

J Psychiatry Neurosci. 2005 May;30(3):167-75. Review.

11.

The Role of High-Potency Benzodiazepines in the Treatment of Panic Disorder.

Susman J, Klee B.

Prim Care Companion J Clin Psychiatry. 2005;7(1):5-11.

12.

Anxiety and Depression: Optimizing Treatments.

Ballenger JC.

Prim Care Companion J Clin Psychiatry. 2000 Jun;2(3):71-79.

13.

Overview of panic disorder.

Ballenger JC.

Trans Am Clin Climatol Assoc. 1994;105:36-51; discussion 51-3. Review. No abstract available.

14.

Fluoxetine in panic disorder: pharmacologic and tritiated platelet imipramine and paroxetine binding study.

Pecknold JC, Luthe L, Iny L, Ramdoyal D.

J Psychiatry Neurosci. 1995 May;20(3):193-8.

15.

Treating panic.

Tyrer P.

BMJ. 1989 Jan 28;298(6668):201-2. No abstract available.

16.

The division of neurosis: a failed classification.

Tyrer PJ.

J R Soc Med. 1990 Oct;83(10):614-6. Review. No abstract available.

Supplemental Content

Support Center